Ország: Kirgizisztán
Nyelv: orosz
Forrás: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)
Циклосерин
DONG-A ST (DONG-A ST)
Cycloserine
250 мг
капсулы
№100
по рецепту
DONG-A ST (Южная Корея)
ПЖВЛС: нет
2019-10-29
)'TBEPXAAIO 3amecrurerb ArpeKTopa fl,euaprarreHTa JreKapcrBeuHoro o6ecneqesuq tl MeAr.rquucrcofi Texur.rKr{ MuHncrepcrBa 3ApaBooxpaHeHrrfl !xannoporona << 22>> , I,IHCTPyKIII4fl TIOMEAI4UI,IHCKOMyTIPI,IMEHEHLIIOJIBKAPCTBEHHOTO TIPEIIAPATA KJIOCEPTIH@ KAIIC Topronoe Ha3aHrre Knocepuu@ xanc Mex4yHapoAHoe He[areHToBaHHoe Ha3aHrre I-{zxrocepuu JlercapcrneHHas Qopvra Kaucy"nrr Cocran KaNAax Kailcyna coAepxr.rr: I-{urc,rocepuH..................... 250 urr (4eficrryrouiee neulecrno) Ta,rrr........ 25 ur Ilurqeeofi Kpacurenb: P3&C xpacunft #3 (C1 # 45430) P3&C Nerrufi #6 (C1# 15985) Onucanue Taepaar xeJlaruHoBaf, KarIcyJIa c po3oBbrM KornarrroM u 6eruu KoplycoM HanoJrHeHa troporuKoM or 6e.rroro Ao cnerKa xeJrroBaroro uBera. Oapnrarcorepa[eBTuqecnar rpynfla : flporunovruxpo6urte rperaparbr An"rr crrcreMHoro ucroJrb3oBanrrr. flporurory6eprynesnue rperaparbr. Anru6arrepuiurbHbre flperaparrr. I{rarnocepuH. Kos ATX J04AB01 O apnaxo.norr.rq ecxlle cs o fi crn a {DapnaxoxuHemaKa IfiaxnocepuH 6rtcrpo BcacblBaercfl u3 xeny.{orrHo-KuueqHoro rpaKTa rrocJre rrppreMa BHyrpb, Aocrl,Irarl onpeAenf,eMblx xouqeurpaquft B [Jra3Me B TerreHl,re oAHoro r{aca, ceo6oAHo pactrpeAeJlflercfl B xl,IAKocrflx vr. TKaH.rrx opraHr{3Ma. I-[uxlocepuu upoHr,rKaer trepe3 reMaro3Hlleipalnuecxr,rfi 6aprep, KoHrleHTparlr4r,r B qepe6pocnuualrnofi xr4Axocrr{ rrprrMepHo Tarue xe, KaK u B IIJIa3Me KpoBr{. Oxoao 66 % Ao3br npelapara BbrBoAr{Tc, 0 Moqoft B HeI{3MeHeHHoM BLIAe B TeqeHr.re 24 qacos. l0 % - B Teqeur,re cJre.{yrcuux 48 .racos. C xalou BbIBoAflTcr He3HarII4TeJIbHbre Korr,rqecrBa. Orolo 35 o/o ueru6orr.r3r.rpyrorcf,, Ho uera6orulru Ao Hacro.f,rqero BpeMeHr,r He r,rAeHrr{0r4ur{poBarrbr. lleprao4 noJryBhrBereHr{, qr.{KJrocepr{Ha HaxoAllrcfl B rlpe.{enax 8-12 qacoB. Ilur-rrocepuu rrpoHr.rxaer qepe3 rrJrarleHTy. B 6prounofi u rlreBpaJlbHoft norocrl'I coAepxl{rc, 50-100 0Z or xouqeHTparlrr npeflapara B cbrBoporKe KpoBr{. llpu xpouuqecxoft uoqeqHofi HeAocraroquocrrr trep$ 14 gn 'Nroryr Bo3Hr.rKHyrb ,BJreHr{f, wynfllI]II AaptwaxoduHorwuKa I-{rauoceprau frBlrfl Olvassa el a teljes dokumentumot